Mina Lobbous, MD, MPH, discusses findings and implications fro a study investigating a new regimen for the treatment of brain metastases in patients with HER2-positive breast cancer.
Mina Lobbous, MD, MPH
Advertisement
Mina Lobbous, MD, MPH, is an oncologist in the Brain Tumor and Neuro-Oncology Center at Cleveland Clinic.
Articles by Mina Lobbous, MD, MPH
Advertisement
Latest Updated Articles
Brain Benefits: Targeted Therapy Offers New Weapon Against HER2+ Breast Cancer with LMPublished: July 5th 2024 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
